The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Nanobodies and Their Potential Applications
Abstract
Nanobodies are recombinant, antigen-specific, single-domain, variable fragments of camelid heavy chain-only antibodies. The innate supremacy of nanobodies as a renewable source of affinity reagents, together with their high production yield in a broad variety of expression systems, minimal size, great stability, reversible refolding and outstanding solubility in aqueous solutions, and ability to specifically recognize unique epitopes with subnanomolar affinity, have combined to make them a useful class of biomolecules for research and various medical diagnostic and therapeutic applications. This article speculates on a number of technological innovations that might be introduced in the nanobody identification platform to streamline the generation of more potent nanobodies and to expand their application range.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naturally occurring antibodies devoid of light chains
Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hammers, C., Songa, E. B., Bendahman, N., & Hammers, R. (1993) · Nature · doi:10.1038/363446a0 · Cited by 3,241
Self-citationStructure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
A system for the continuous directed evolution of biomolecules
Esvelt, K. M., Carlson, J. C., & Liu, D. R. (2011) · Nature · doi:10.1038/nature09929 · Cited by 699
A Versatile Nanotrap for Biochemical and Functional Studies with Fluorescent Fusion Proteins
Rothbauer, U., Zolghadr, K., Muyldermans, S., Schepers, A., Cardoso, M. C., & Leonhardt, H. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700342-mcp200 · Cited by 677
Self-citationMolecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
De Genst, E., Silence, K., Decanniere, K., Conrath, K., Loris, R., Kinne, J., Muyldermans, S., & Wyns, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505379103 · Cited by 676
Self-citationBispecific T-Cell Engaging Antibodies for Cancer Therapy
Baeuerle, P. A., & Reinhardt, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0547 · Cited by 592
Strategies for extended serum half-life of protein therapeutics
Kontermann, R. E. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.012 · Cited by 573
Vincke, C., Loris, R., Saerens, D., Martinez-Rodriguez, S., Muyldermans, S., & Conrath, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806889200 · Cited by 572
Self-citationA simple, versatile method for GFP-based super-resolution microscopy via nanobodies
Ries, J., Kaplan, C., Platonova, E., Eghlidi, H., & Ewers, H. (2012) · Nature Methods · doi:10.1038/nmeth.1991 · Cited by 571
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
Wesolowski, J., Alzogaray, V., Reyelt, J., Unger, M., Juarez, K., Urrutia, M., Cauerhff, A., Danquah, W., Rissiek, B., Scheuplein, F., et al. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0116-7 · Cited by 513
Fluorescent fusion protein knockout mediated by anti-GFP nanobody
Caussinus, E., Kanca, O., & Affolter, M. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2180 · Cited by 510
Efficient Cancer Therapy with a Nanobody-Based Conjugate
Cortez-Retamozo, V., Backmann, N., Senter, P. D., Wernery, U., De Baetselier, P., Muyldermans, S., & Revets, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3935 · Cited by 382
Self-citationVan de Broek, B., Devoogdt, N., D’Hollander, A., Gijs, H.-L., Jans, K., Lagae, L., Muyldermans, S., Maes, G., & Borghs, G. (2011) · ACS Nano · doi:10.1021/nn1023363 · Cited by 374
Self-citationEfficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Roovers, R. C., Laeremans, T., Huang, L., De Taeye, S., Verkleij, A. J., Revets, H., de Haard, H. J., & van Bergen en Henegouwen, P. M. P. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0180-4 · Cited by 346
Bispecific antibodies for cancer therapy: The light at the end of the tunnel?
Chames, P., & Baty, D. (2009) · mAbs · doi:10.4161/mabs.1.6.10015 · Cited by 336
Tijink, B. M., Laeremans, T., Budde, M., Walsum, M. S.-V., Dreier, T., de Haard, H. J., Leemans, C. R., & van Dongen, G. A. M. S. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2384 · Cited by 305
Coppieters, K., Dreier, T., Silence, K., Haard, H. D., Lauwereys, M., Casteels, P., Beirnaert, E., Jonckheere, H., Wiele, C. V. D., Staelens, L., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21827 · Cited by 303
Reddy, S. T., Ge, X., Miklos, A. E., Hughes, R. A., Kang, S. H., Hoi, K. H., Chrysostomou, C., Hunicke-Smith, S. P., Iverson, B. L., Tucker, P. W., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1673 · Cited by 292
Movahedi, K., Schoonooghe, S., Laoui, D., Houbracken, I., Waelput, W., Breckpot, K., Bouwens, L., Lahoutte, T., De Baetselier, P., Raes, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2994 · Cited by 291
Self-citationA biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growth
Roovers, R. C., Vosjan, M. J. W. D., Laeremans, T., el Khoulati, R., de Bruin, R. C. G., Ferguson, K. M., Verkleij, A. J., van Dongen, G. A. M. S., & van Bergen en Henegouwen, P. M. P. (2011) · International Journal of Cancer · doi:10.1002/ijc.26145 · Cited by 284
Biopanning and rapid analysis of selective interactive ligands
Giordano, R. J., Cardó‐Vila, M., Lahdenranta, J., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1249 · Cited by 276
Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins
McNaughton, B. R., Cronican, J. J., Thompson, D. B., & Liu, D. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807883106 · Cited by 266
Muruganandam, A., Tanha, J., Narang, S., & Stanimirovic, D. (2002) · The FASEB Journal · doi:10.1096/fj.01-0343fje · Cited by 260
Jähnichen, S., Blanchetot, C., Maussang, D., Gonzalez-Pajuelo, M., Chow, K. Y., Bosch, L., De Vrieze, S., Serruys, B., Ulrichts, H., Vandevelde, W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012865107 · Cited by 250
Protein transduction domain delivery of therapeutic macromolecules
van den Berg, A., & Dowdy, S. F. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.03.008 · Cited by 247
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme
Dumoulin, M., Last, A. M., Desmyter, A., Decanniere, K., Canet, D., Larsson, G., Spencer, A., Archer, D. B., Sasse, J., Muyldermans, S., et al. (2003) · Nature · doi:10.1038/nature01870 · Cited by 246
Self-citationHabicht, G., Haupt, C., Friedrich, R. P., Hortschansky, P., Sachse, C., Meinhardt, J., Wieligmann, K., Gellermann, G. P., Brodhun, M., Götz, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703793104 · Cited by 218
Li, T., Bourgeois, J., Celli, S., Glacial, F., Le Sourd, A., Mecheri, S., Weksler, B., Romero, I., Couraud, P., Rougeon, F., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-201384 · Cited by 202
Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions
Broisat, A., Hernot, S., Toczek, J., De Vos, J., Riou, L. M., Martin, S., Ahmadi, M., Thielens, N., Wernery, U., Caveliers, V., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.265140 · Cited by 200
Self-citationAntibody repertoire development in camelids
De Genst, E., Saerens, D., Muyldermans, S., & Conrath, K. (2006) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2005.06.010 · Cited by 193
Self-citationImmunomodulation of enzyme function in plants by single-domain antibody fragments
Jobling, S. A., Jarman, C., Teh, M.-M., Holmberg, N., Blake, C., & Verhoeyen, M. E. (2003) · Nature Biotechnology · doi:10.1038/nbt772 · Cited by 186
Single-domain antibodies as building blocks for novel therapeutics
SAERENS, D., GHASSABEH, G., & MUYLDERMANS, S. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.07.006 · Cited by 186
Self-citationUlrichts, H., Silence, K., Schoolmeester, A., de Jaegere, P., Rossenu, S., Roodt, J., Priem, S., Lauwereys, M., Casteels, P., Van Bockstaele, F., et al. (2011) · Blood · doi:10.1182/blood-2010-11-317859 · Cited by 184
Vincke, C., Gutiérrez, C., Wernery, U., Devoogdt, N., Hassanzadeh-Ghassabeh, G., & Muyldermans, S. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-974-7_8 · Cited by 180
Self-citationFlajnik, M. F., Deschacht, N., & Muyldermans, S. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001120 · Cited by 176
Self-citationDiGiandomenico, A., Warrener, P., Hamilton, M., Guillard, S., Ravn, P., Minter, R., Camara, M. M., Venkatraman, V., MacGill, R. S., Lin, J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120033 · Cited by 174
Ravn, U., Gueneau, F., Baerlocher, L., Osteras, M., Desmurs, M., Malinge, P., Magistrelli, G., Farinelli, L., Kosco-Vilbois, M. H., & Fischer, N. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq789 · Cited by 173
Broersen, K., Rousseau, F., & Schymkowitz, J. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt36 · Cited by 168
Protein PEGylation Decreases Observed Target Association Rates via a Dual Blocking Mechanism
Kubetzko, S., Sarkar, C. A., & Plückthun, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014910 · Cited by 163
‘Camelising’ human antibody fragments: NMR studies on VH domains
Davies, J., & Riechmann, L. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80432-x · Cited by 158
SbsB structure and lattice reconstruction unveil Ca2+ triggered S-layer assembly
Baranova, E., Fronzes, R., García-Pino, A., Gerven, N. V., Papapostolou, D., Pehau‐Arnaudet, G., Pardon, E., Steyaert, J., Howorka, S., & Remaut, H. K. (2012) · Nature · doi:10.1038/nature11155 · Cited by 157
Engineering of recombinant crystallization chaperones
Koide, S. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.04.008 · Cited by 154
Immuno-imaging using nanobodies
Vaneycken, I., D’Huyvetter, M., Hernot, S., Vos, J. D., Xavier, C., Devoogdt, N., Caveliers, V., & Lahoutte, T. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.009 · Cited by 142
Self-citationMonegal, A., Ami, D., Martinelli, C., Huang, H., Aliprandi, M., Capasso, P., Francavilla, C., Ossolengo, G., & de Marco, A. (2009) · Protein Engineering Design and Selection · doi:10.1093/protein/gzp002 · Cited by 139
A bispecific nanobody to provide full protection against lethal scorpion envenoming
Hmila, I., Saerens, D., Abderrazek, R. B., Vincke, C., Abidi, N., Benlasfar, Z., Govaert, J., Ayeb, M. E., Bouhaouala‐Zahar, B., & Muyldermans, S. (2010) · The FASEB Journal · doi:10.1096/fj.09-148213 · Cited by 125
Self-citationCrystal Structure of the Intrinsically Flexible Addiction Antidote MazE
Loris, R., Marianovsky, I., Lah, J., Laeremans, T., Engelberg–Kulka, H., Glaser, G., Muyldermans, S., & Wyns, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302336200 · Cited by 123
Self-citationKoch‐Nolte, F., Reyelt, J., Schößow, B., Schwarz, N., Scheuplein, F., Rothenburg, S., Haag, F., Alzogaray, V., Cauerhff, A., & Goldbaum, F. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-8661com · Cited by 123
Lafaye, P. J., Achour, I., England, P., Duyckaerts, C. J., & Rougeon, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.008 · Cited by 121
Domanska, K., Vanderhaegen, S., Srinivasan, V., Pardon, E., Dupeux, F., Márquez, J. A., Giorgetti, S., Stoppini, M., Wyns, L., Bellotti, V., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008560108 · Cited by 119
Nanobody; an Old Concept and New Vehicle for Immunotargeting
Rahbarizadeh, F., Ahmadvand, D., & Sharifzadeh, Z. (2011) · Immunological Investigations · doi:10.3109/08820139.2010.542228 · Cited by 117
Talelli, M., Rijcken, C. J. F., Oliveira, S., van der Meel, R., Henegouwen, P. M. P. V. B. E., Lammers, T., van Nostrum, C. F., Storm, G., & Hennink, W. E. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.015 · Cited by 114
Nanobody-coupled microbubbles as novel molecular tracer
Hernot, S., Unnikrishnan, S., Du, Z., Shevchenko, T. I., Cosyns, B., Broisat, A., Toczek, J., Caveliers, V., Muyldermans, S., Lahoutte, T., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.007 · Cited by 98
Self-citationResearch strategies to improve snakebite treatment: Challenges and progress
Harrison, R. A., Cook, D. A. N., Renjifo, C., Casewell, N. R., Currier, R. B., & Wagstaff, S. C. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.06.019 · Cited by 89
Generation of heavy-chain-only antibodies in mice
Janssens, R., Dekker, S., Hendriks, R. W., Panayotou, G., van Remoortere, A., San, J. K. A., Grosveld, F. G., & Drabek, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601108103 · Cited by 89
Harmsen, M. M., van Solt, C. B., Fijten, H., & Setten, M. C. V. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.05.017 · Cited by 87
Advances in bispecific biotherapeutics for the treatment of cancer
May, C., Sapra, P., & Gerber, H. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.011 · Cited by 87
Iqbal, U. H., Trojahn, U., Albaghdadi, H., Zhang, J., O'Connor‐McCourt, M. D., Stanimirovic, D. B., Tomanek, B., Sutherland, G. R., & Abulrob, A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00742.x · Cited by 85
Koide, A., Tereshko, V., Uysal, S., Margalef, K., Kossiakoff, A. A., & Koide, S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.08.027 · Cited by 85
Olichon, A., & Surrey, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704908200 · Cited by 84
Pollithy, A., Romer, T., Lang, C., Müller, F. D., Helma, J., Leonhardt, H., Rothbauer, U., & Schüler, D. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05282-11 · Cited by 79
Verheesen, P., ten Haaft, M. R., Lindner, N. M., Verrips, C. T., & de Haard, J. J. W. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2003.09.006 · Cited by 78
Joshi, S. N., Butler, D. C., & Messer, A. C. (2012) · mAbs · doi:10.4161/mabs.21696 · Cited by 74
Tereshko, V. A., Uysal, S., Koide, A., Margalef, K., Koide, S., & Kossiakoff, A. A. (2008) · Protein Science · doi:10.1110/ps.034892.108 · Cited by 71
Biopharmaceutical drug discovery using novel protein scaffolds
Gill, D. S., & Damle, N. K. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.10.003 · Cited by 67
Vugmeyster, Y., Entrican, C., Joyce, A. P., Lawrence-Henderson, R. F., Leary, B. A., Mahoney, C. S., Patel, H. K., Raso, S. W., Olland, S., Hegen, M., et al. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300066a · Cited by 66
Stijlemans, B., Caljon, G., Natesan, S. K. A., Saerens, D., Conrath, K., Pérez-Morga, D. L., Skepper, J. N., Nikolaou, A., Brys, L., Pays, É., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002072 · Cited by 66
Self-citationDirect Injection of Functional Single-Domain Antibodies from E. coli into Human Cells
Blanco‐Toribio, A., Muyldermans, S., Frankel, G. M., & Fernández, L. Á. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015227 · Cited by 64
Self-citationCancer therapy with bispecific antibodies: Clinical experience.
Thakur, A. B., & Lum, L. G. (2010) · PubMed · Cited by 63
Improved anti-IgG and HSA affinity ligands: Clinical application of VHH antibody technology
Klooster, R., Maassen, B., Stam, J. C., Hermans, P., ten Haaft, M. R., Detmers, F. J. M., de Haard, H., Post, J. A., & Verrips, C. T. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.04.005 · Cited by 63
Engineering antibodies and proteins for molecular in vivo imaging
Romer, T., Leonhardt, H., & Rothbauer, U. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.007 · Cited by 63
Using microdialysis to analyse the passage of monovalent nanobodies through the blood–brain barrier
Caljon, G., Caveliers, V., Lahoutte, T., Stijlemans, B., Ghassabeh, G. H., Abbeele, J. V. D., Smolders, I. J., BAETSELIER, P. D., Michotte, Y. M., Muyldermans, S., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01723.x · Cited by 62
Self-citationPellis, M., Pardon, E., Zolghadr, K., Rothbauer, U., Vincke, C., Kinne, J., Dierynck, I., Hertogs, K., Leonhardt, H., Messens, J., et al. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.04.023 · Cited by 56
Self-citationAnti-MUC1 Nanobody Can Redirect T-Body Cytotoxic Effector Function
Aghaee‐Bakhtiari, S. H., Rahbarizadeh, F., Hasannia, S., Ahmadvand, D., Sofla, F. J. I., & Rasaee, M. J. (2009) · Hybridoma · doi:10.1089/hyb.2008.0079 · Cited by 53
Genst, E. D., Areskoug, D., Decanniere, K., Muyldermans, S., & Andersson, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202359200 · Cited by 52
Self-citationClercq, S. D., Zwaenepoel, O., Martens, E., Vandekerckhove, J. S., Guillabert, A., & Gettemans, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1169-0 · Cited by 46
Single Domain Intracellular Antibodies from Diverse Libraries
Tanaka, T. U., Sewell, H., Waters, S., Phillips, S. E. V., & Rabbitts, T. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188193 · Cited by 43
Altıntaş, I., Kok, R. J., & Schiffelers, R. M. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.015 · Cited by 43
Abbady, A. Q., Al-Daoude, A., Al-Mariri, A., Zarkawi, M., & Muyldermans, S. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.01.015 · Cited by 39
Self-citationHmila, I., Cosyns, B., Tounsi, H., Roosens, B., Caveliers, V., Abderrazek, R. B., Boubaker, S., Muyldermans, S., Ayeb, M. E., Bouhaouala‐Zahar, B., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.033 · Cited by 32
Self-citationKlooster, R., Eman, M. R., le Duc, Q., Verheesen, P., Verrips, C. T., Roovers, R. C., & Post, J. A. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.10.009 · Cited by 29
Specific immuno capturing of the Staphylococcal superantigen toxic‐shock syndrome toxin‐1 in plasma
Adams, H., Brummelhuis, W. J., Maassen, B., van Egmond, N., Khattabi, M. E., Detmers, F. J. M., Hermans, P., Braam, B. G., Stam, J. C., & Verrips, T. C. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22365 · Cited by 25
Generation of Anti-infectome/Anti-proteome Nanobodies
Hassanzadeh‐Ghassabeh, G., Saerens, D., & Muyldermans, S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-319-6_19 · Cited by 16
Self-citationNanobodies as Structural Probes of Protein Misfolding and Fibril Formation
Genst, E. D., & Dobson, C. M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-968-6_34 · Cited by 16
Biotinylated Bionanocapsules for Displaying Diverse Ligands Toward Cell-specific Delivery
Shishido, T., Azumi, Y., Nakanishi, T., Umetsu, M., Tanaka, T., Ogino, C., Fukuda, H., & Kondo, A. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp134 · Cited by 15
Clinical Experience with Gene Therapy and Bispecific Antibodies for T Cell-based Therapy of Cancer
Baeuerle, P. A., & Itin, C. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800785005 · Cited by 9
Cited by
The therapeutic potential of nanobodies
Jovčevska, I., & Muyldermans, S. (2020) · BioDrugs · doi:10.1007/s40259-019-00392-z · Cited by 749
Self-citationNanoparticle-Based Immunochemical Biosensors and Assays: Recent Advances and Challenges
Farka, Z., Juřík, T., Kovář, D., Trnková, L., & Skládal, P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00037 · Cited by 694
Biosensors for Whole-Cell Bacterial Detection
Ahmed, A., Rushworth, J. V., Hirst, N. A., & Millner, P. A. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00120-13 · Cited by 666
Antibody Structure and Function: The Basis for Engineering Therapeutics
Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 638
Point-of-Care Diagnostics: Recent Developments in a Connected Age
Nayak, S., Blumenfeld, N. R., Laksanasopin, T., & Sia, S. K. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04630 · Cited by 508
Metadata
- Authors
- Hassanzadeh-Ghassabeh, G., Devoogdt, N., De Pauw, P., Vincke, C., & Muyldermans, S.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2013-06
- Volume
- 8
- Issue
- 6
- Pages
- 1013-1026
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2100355920
- Cited by
- 328
- References
- 85
- FWCI
- 12.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.